N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 3 ClinicalTrials.gov

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Sponsor: Merck Sharp & Dohme LLC • ClinicalTrials.gov ID: NCT06667700

Registry updated: 2026-10-20
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symptoms. However, people with certain health conditions or other factors have a high risk (chance) of getting severely ill from COVID-19, which can require a hospital stay or lead to death. Some people who are high risk for severe illness may be unable to take certain treatments for COVID-19 because they are not available to them, or they take other medicines that may react with a treatment and cause an unwanted effect. Molnupiravir (MK-4482) is a study medicine designed to stop the COVID-19 virus from copying itself in the body (multiplying). The goal of this study is to learn if molnupiravir prevents severe illness from COVID-19 more than placebo in people who are high risk.

Interventions

  • Molnupiravir (Drug)
    Molnupiravir administered orally as two 400 mg film-coated tablets every 12 hours for 5 days (a total of 10 consecutive doses)
  • Placebo (Drug)
    Molnupiravir-matching placebo administered orally as two film-coated tablets every 12 hours for 5 days (a total of 10 consecutive doses)

Eligibility criteria

Inclusion Criteria The main inclusion criteria include but are not limited to the following: * Is an individual of any sex/gender, ≥18 years of age * Has documentation of SARS-CoV-2 infection with sample collection ≤4 days prior to randomization * Has initial onset of signs/symptoms attributable to COVID-19 for ≤4 days prior to the day of randomization and ≥2 of the following signs/symptoms attributable to COVID-19 on the day of randomization: cough, sore throat, nasal congestion, shortness of breath or difficulty breathing with exertion, muscle or body aches, fatigue, fever \>38.0°C or chills, nausea or vomiting or diarrhea, change in sense of smell or change in sense of taste, or headache * Has ≥1 of the following characteristics or medical conditions associated with the highest risk of severe illness from COVID-19: * Advanced age of ≥75 years of age * Immunocompromised * Neurocognitive or physical disability * Has ≥3 characteristics or medical conditions which increase the risk of severe illness due to COVID-19 (e.g., chronic lung disease, obesity with body mass index (BMI) ≥35, diabetes) * Is unable or unwilling to receive treatment with nirmatrelvir/ritonavir (NMV/r) due to 1 or more of the following: * Is receiving drug(s) highly dependent on cytochrome P450 3A (CYP3A) for clearance and for which elevated concentrations are associated with serious and/or life-threatening consequences or drug(s) with a clinically significant drug-drug interaction for which co-administration is not possible * Is receiving potent CYP3A inducers where significantly reduced nirmatrelvir or ritonavir plasma concentrations may be associated with the potential for loss of virologic response and possible resistance * Has severe hepatic impairment * Has experienced prior adverse reactions or hepatotoxicity to NMV/r that would preclude future use * Has known or suspected NMV/r resistance * Has uncontrolled HIV infection * NMV/r is not approved/authorized in the participant's country or it is not accessible to participant (e.g., drug shortage) * Is unwilling to receive treatment with NMV/r Inclusion note: Participants may receive remdesivir as standard of care in addition to molnupiravir or placebo. If remdesivir is available and clinically appropriate per local clinical practice, investigators will aim to ensure that those who are most vulnerable to severe COVID-19 receive timely access to remdesivir as standard of care on this study. Exclusion Criteria The main exclusion criteria include but are not limited to the following: * Is currently hospitalized or is expected to need hospitalization for COVID-19 imminently * Has received or plans to receive SARS-CoV-2 directed oral antivirals or monoclonal antibodies for current episode of COVID-19 (other than study intervention and, if applicable, remdesivir as standard of care) * Has ≥1 of the following signs/symptoms that are attributable to severe or critical COVID-19: * Shortness of breath at rest * Respiratory rate ≥30 breaths per minute * Heart rate ≥125 beats per minute * Peripheral oxygen saturation (SpO2) ≤93% on room air or on supplemental oxygen for a reason other than COVID-19 which has not increased since onset of COVID-19 signs/symptoms * New or increasing need for supplemental oxygen: receiving \>4 liters/minute supplemental oxygen due to COVID-19 OR on supplemental oxygen for a reason other than COVID-19 which has increased due to COVID-19 * Has received a COVID-19 vaccine within 30 days prior to randomization * Has a history of confirmed influenza, respiratory syncytial virus (RSV), or SARS-CoV-2 infection (with or without symptoms; excluding current infection) within 30 days prior to randomization * Has known or suspected hypersensitivity to active or inactive ingredients of molnupiravir

Conditions

Coronavirus Disease (COVID-19)

Locations

  • Cullman Clinical Trials ( Site 3813) — Cullman, Alabama, United States
  • Helios Clinical Research ( Site 3826) — Paradise Valley, Arizona, United States
  • Absolute Clinical Research ( Site 3709) — Phoenix, Arizona, United States
  • Clinica de Salud del Valle de Salinas ( Site 3825) — Castroville, California, United States
  • Ascada Health PC dba Ascada Research ( Site 3750) — Fullerton, California, United States
  • Pacific Clinical Studies ( Site 3827) — Los Alamitos, California, United States
  • Valley Clinical Trials, Inc. ( Site 3707) — Northridge, California, United States
  • FOMAT Medical Research ( Site 3720) — Oxnard, California, United States
  • Paradigm Clinical Research, LLC ( Site 3785) — San Diego, California, United States
  • Optimus Medical ( Site 3817) — San Francisco, California, United States
  • Millennium Clinical Trials ( Site 3758) — Westlake Village, California, United States
  • Paradigm Clinical Research Centers, Inc ( Site 3718) — Wheat Ridge, Colorado, United States
  • Encore Medical Research of Boynton Beach ( Site 3701) — Boynton Beach, Florida, United States
  • Prestige Clinical Research Center ( Site 3722) — Coral Gables, Florida, United States
  • Prestige Clinical Research ( Site 3830) — Homestead, Florida, United States
  • Accel Research Sites Network - St. Pete-Largo Clinical Research Unit ( Site 3779) — Largo, Florida, United States
  • Clinical Site Partners, LLC dba Flourish Research ( Site 3717) — Leesburg, Florida, United States
  • Advanced Pulmonary Research Institute ( Site 3781) — Loxahatchee Groves, Florida, United States
  • Southern Clinical Research ( Site 3773) — Miami, Florida, United States
  • Florida Pharmaceutical Research and Associates ( Site 3763) — Miami, Florida, United States
  • Bio-Medical Research LLC ( Site 3804) — Miami, Florida, United States
  • Bright Research Center ( Site 3746) — Miami, Florida, United States
  • Miami Clinical Research ( Site 3729) — Miami, Florida, United States
  • Reed Medical Research ( Site 3761) — Miami, Florida, United States
  • Palm Springs Community Health Center ( Site 3757) — Miami Lakes, Florida, United States
  • Panax Clinical Research ( Site 3803) — Miami Lakes, Florida, United States
  • Indago Research and Health Center Inc ( Site 3714) — Miami Lakes, Florida, United States
  • Combined Research Orlando Phase I-IV ( Site 3797) — Orlando, Florida, United States
  • CDC Research Institute ( Site 3716) — Port Saint Lucie, Florida, United States
  • New Tampa Health ( Site 3764) — Tampa, Florida, United States
  • Clinical Research Trials of Florida ( Site 3703) — Tampa, Florida, United States
  • Precision Research Center ( Site 3704) — Tampa, Florida, United States
  • Encore Medical Research - Weston ( Site 3708) — Weston, Florida, United States
  • Balanced Life Health Care Solutions/SKYCRNG ( Site 3713) — Lawrenceville, Georgia, United States
  • Renew Health Clinical Research ( Site 3760) — Snellville, Georgia, United States
  • Rophe Adult and Pediatric Medicine/SKYCRNG ( Site 3816) — Union City, Georgia, United States
  • Paradigm Clinical Research - Boise ( Site 3841) — Boise, Idaho, United States
  • Rush University Medical Center ( Site 3748) — Chicago, Illinois, United States
  • Duly Health and Care ( Site 3799) — Lombard, Illinois, United States
  • University of Louisville School of Medicine ( Site 3706) — Louisville, Kentucky, United States
  • Barnum Medical Research ( Site 3828) — Natchitoches, Louisiana, United States
  • Annapolis Internal Medicine - CCT Research ( Site 3700) — Annapolis, Maryland, United States
  • Kur Research - Columbia Medical ( Site 3767) — Columbia, Maryland, United States
  • Revival Research Institute, LLC ( Site 3835) — Dearborn, Michigan, United States
  • Michigan Center of Medical Research (MICHMER) ( Site 3734) — Farmington Hills, Michigan, United States
  • Henry Ford St John TM Center for Infectious Disease Research ( Site 3766) — Grosse Pointe Woods, Michigan, United States
  • Mankato Clinic ( Site 3842) — Mankato, Minnesota, United States
  • Prime Health and Wellness/SKYCRNG ( Site 3726) — Fayette, Mississippi, United States
  • SKY Integrative Medical Center/SKYCRNG ( Site 3740) — Ridgeland, Mississippi, United States
  • Nevada Health Centers ( Site 3840) — Carson City, Nevada, United States
  • WR-CRCN, LLC ( Site 3818) — Las Vegas, Nevada, United States
  • Saint Michael's Medical Center ( Site 3808) — Newark, New Jersey, United States
  • Holy Name Medical Center ( Site 3807) — Teaneck, New Jersey, United States
  • Weill Cornell Medical College ( Site 3814) — New York, New York, United States
  • Prime Global Research ( Site 3731) — The Bronx, New York, United States
  • OnSite Clinical Solutions ( Site 3784) — Charlotte, North Carolina, United States
  • Monroe Biomedical Research ( Site 3732) — Monroe, North Carolina, United States
  • IMA Clinical Research Mount Airy ( Site 3745) — Mount Airy, North Carolina, United States
  • Research Innovations, LLC ( Site 3712) — Beavercreek, Ohio, United States
  • Midlands Neurology & Pain Associates ( Site 3751) — Columbia, South Carolina, United States
  • Helios Clinical Research - JAC ( Site 3833) — Jackson, Tennessee, United States
  • Javara - Privia Medical Group Gulf Coast - The Woodlands HWH ( Site 3837) — Conroe, Texas, United States
  • South Texas Clinical Research ( Site 3815) — Corpus Christi, Texas, United States
  • Care United Research, LLC ( Site 3747) — Forney, Texas, United States
  • Houston Methodist Hospital ( Site 3800) — Houston, Texas, United States
  • MD Anderson ( Site 3843) — Houston, Texas, United States
  • Andres Garcia Zuniga, M.D., P.A. ( Site 3782) — Laredo, Texas, United States
  • LinQ Research ( Site 3824) — Pearland, Texas, United States
  • Crossroads Clinical Research-Family Practice ( Site 3739) — Victoria, Texas, United States
  • Velocity Clinical Research - Hampton ( Site 3744) — Hampton, Virginia, United States
  • Eastside Research Associates ( Site 3727) — Redmond, Washington, United States
  • CEMIC ( Site 0101) — Buenos Aires., Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires ( Site 0107) — Ciudad Autonoma de Buenos Aires., Buenos Aires, Argentina
  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 0111) — Mar del Plata, Buenos Aires, Argentina
  • Nefra Medical Care - Moron ( Site 0109) — Morón, Buenos Aires, Argentina
  • Hospital Felicio Rocho (HFR) - Nucleo de Ciencias da Saude ( Site 0402) — Belo Horizonte, Minas Gerais, Brazil
  • Instituto Atena de Pesquisa Clinica ( Site 0406) — Natal, Rio Grande do Norte, Brazil
  • Centro de Pesquisa em Medicina Tropical - CEPEM - Rondonia ( Site 0405) — Porto Velho, Rondônia, Brazil
  • Centro de Pesquisa Sao Lucas ( Site 0401) — Campinas, São Paulo, Brazil
  • Centro de Pesquisa Clinica Institucional do HCFMUSP - CPCi ( Site 0403) — São Paulo, Brazil
  • Medical Center Asclepius ( Site 0506) — Velingrad, Pazardzhik, Bulgaria
  • Medical Center Zdrave 1 ( Site 0509) — Kozloduy, Vratsa, Bulgaria
  • Medical Center 'Medconsult' Burgas EOOD ( Site 0510) — Burgas, Bulgaria
  • Medconsult Pleven - Lovech ( Site 0501) — Lovech, Bulgaria
  • Medical Center Hera ( Site 0507) — Montana, Bulgaria
  • MHAT "Dr. Stamen Iliev" Montana-Department of Pulmonology ( Site 0504) — Montana, Bulgaria
  • Medconsult Pleven ( Site 0503) — Pleven, Bulgaria
  • DKC V - Plovdiv ( Site 0508) — Plovdiv, Bulgaria
  • SHATPPD Dr. Dimitar Gramatikov - Ruse EOOD ( Site 0502) — Rousse, Bulgaria
  • Diagnostic Consultative Center 22 - Sofia ( Site 0500) — Sofia, Bulgaria
  • Medical Center Hera EOOD ( Site 0505) — Sofia, Bulgaria
  • Medical Centre Pratia Clinic EOOD ( Site 0511) — Varna, Bulgaria
  • IPS SURA San Diego ( Site 0806) — Medellín, Antioquia, Colombia
  • IPS Centro Científico Asistencial S.A.S ( Site 0800) — Barranquilla, Atlántico, Colombia
  • Clinica Colsanitas - Sede Reina Sofia ( Site 0807) — Bogotá, Bogota D.C., Colombia
  • Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 0804) — Bogotá, Bogota D.C., Colombia
  • Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0801) — Valledupar, Cesar Department, Colombia
  • IMAT S.A.S ( Site 0805) — Montería, Departamento de Córdoba, Colombia
  • Fundación Valle del Lili ( Site 0803) — Cali, Valle del Cauca Department, Colombia
  • MeVac - Meilahti Vaccine Research Center ( Site 1200) — Helsinki, Uusimaa, Finland
  • Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital F-Centre d'Investigation Clinique - Plur ( Site 1301) — Dijon, Bourgogne-Franche-Comté, France
  • CHU de Saint-Etienne ( Site 1302) — Saint Priest En Jarez, Pays de la Loire Region, France
  • centre hospitalier lyon sud ( Site 1303) — Pierre-Bénite, Rhone, France
  • Pitie Salpetriere University Hospital-Infectious Disease - Tropical Diseases ( Site 1300) — Paris, Île-de-France Region, France
  • Clinic Health - Batumi ( Site 1405) — Batumi, Adjara, Georgia
  • Family Medical Regional Center ( Site 1404) — Batumi, Adjara, Georgia
  • LTD High Technology Hospital Medcenter ( Site 1408) — Batumi, Adjara, Georgia
  • University Clinic of Innovative Medicine ( Site 1400) — Batumi, Adjara, Georgia
  • Caucasus Medical Centre ( Site 1406) — Tbilisi, Adjara, Georgia
  • "Georgian Clinics" JSC ( Site 1410) — Zugdidi, Samegrelo and Zemo Svaneti, Georgia
  • New Hospitals ( Site 1409) — Tbilisi, Georgia
  • Curatio Clinic - Main Location ( Site 1401) — Tbilisi, Georgia
  • TUM Klinikum ( Site 1502) — Munich, Bavaria, Germany
  • Universitätsklinikum Frankfurt Goethe-Universität ( Site 1503) — Frankfurt am Main, Hesse, Germany
  • Universitaetsklinikum Koeln ( Site 1505) — Cologne, North Rhine-Westphalia, Germany
  • Campus Charite Mitte Nephrologie und Internistische Intensivmedizin ( Site 1501) — Berlin, State of Berlin, Germany
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1904) — Bologna, Italy
  • Ospedale San Martino ( Site 1900) — Genova, Italy
  • ASST Fatebenefratelli Sacco ( Site 1901) — Milan, Italy
  • AOU Pisana- Ospedale Cisanello ( Site 1905) — Pisa, Italy
  • National Hospital Organization Shimoshizu National Hospital ( Site 2007) — Yotsukaidō, Chiba, Japan
  • Tsuchiura Beryl Clinic ( Site 2009) — Tsuchiura, Ibaraki, Japan
  • National Hospital Organization Tokyo National Hospital ( Site 2003) — Kiyose, Tokyo, Japan
  • Sekino Hospital ( Site 2016) — Toshimaku, Tokyo, Japan
  • National Hospital Organization Kyushu Medical Center ( Site 2006) — Fukuoka, Japan
  • Kumamoto Chuo Hospital ( Site 2002) — Kumamoto, Japan
  • Morales Vargas Centro de Investigacion S. C. ( Site 2206) — León, Guanajuato, Mexico
  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 2207) — Guadalajara, Jalisco, Mexico
  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran-Departamento de Infectología ( Site 2203) — Mexico City, Mexico City, Mexico
  • Instituto Nacional de Salud Publica ( Site 2205) — Cuernavaca, Morelos, Mexico
  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Infectologia ( Site 2204) — Monterrey, Nuevo León, Mexico
  • Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatan ( Site 2202) — Mérida, Yucatán, Mexico
  • ICARO Investigaciones en Medicina ( Site 2200) — Chihuahua City, Mexico
  • Arké SMO S.A de C.V-ARKE SMO S.A. de C.V. ( Site 2210) — Veracruz, Mexico
  • CGM Research Trust ( Site 2307) — Christchurch, Canterbury, New Zealand
  • Pacific Clinical Research Network - Tasman ( Site 2304) — Nelson, Tasman District, New Zealand
  • Lakeland Clinical Trials Waikato ( Site 2302) — Nawton, Waikato Region, New Zealand
  • Lakeland Clinical Trials Wellington ( Site 2303) — Upper Hutt, Wellington Region, New Zealand
  • Pacific Clinical Research Network West Auckland ( Site 2301) — Auckland, New Zealand
  • Optimal Clinical Trials North ( Site 2308) — Auckland, New Zealand
  • Silverdale Medical Limited ( Site 2305) — Auckland, New Zealand
  • Optimal Clinical Trials ( Site 2306) — Auckland, New Zealand
  • Asociación Civil Selva Amazónica ( Site 2405) — Iquitos, Loreto, Peru
  • Via Libre ( Site 2409) — Lima, Peru
  • Clinica Ricardo Palma-Centro de Investigacion de Enfermedades Respiratorias Thorax ( Site 2404) — Lima, Peru
  • Health Index Multispeciality Clinic ( Site 2501) — Bacoor, Cavite, Philippines
  • Ospital Ng Makati ( Site 2505) — Makati City, National Capital Region, Philippines
  • Philippine General Hospital-Department of Medicine ( Site 2504) — Manila, National Capital Region, Philippines
  • GreenCity Medical Center ( Site 2503) — San Fernando City, Pampanga, Philippines
  • PL Certus ( Site 2613) — Poznan, Greater Poland Voivodeship, Poland
  • In-Vivo Bydgoszcz ( Site 2601) — Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
  • NZOZ GynCentrum - Oddział Kraków ( Site 2609) — Krakow, Lesser Poland Voivodeship, Poland
  • Penta Hospitals Przychodnie Wrocław Wejherowska ( Site 2611) — Wroclaw, Lower Silesian Voivodeship, Poland
  • Futuremeds Targowek ( Site 2619) — Warsaw, Masovian Voivodeship, Poland
  • FutureMeds Gdynia ( Site 2621) — Gdynia, Pomeranian Voivodeship, Poland
  • NZOZ GynCentrum - Oddział Bielsko-Biała ( Site 2602) — Bielsko-Biala, Silesian Voivodeship, Poland
  • Clinical Medical Research ( Site 2604) — Katowice, Silesian Voivodeship, Poland
  • Holsamed ( Site 2603) — Katowice, Silesian Voivodeship, Poland
  • Centrum Medyczne FutureMeds ( Site 2615) — Lodz, Łódź Voivodeship, Poland
  • Investigadores del Este LLC ( Site 4001) — Humacao, Puerto Rico
  • Miralles Clinical Research LLC ( Site 4004) — San Juan, Puerto Rico
  • MV HEALTH SERVICES LLC ( Site 4003) — San Juan, Puerto Rico
  • Spitalul Clinic de Boli Infecțioase și Tropicale Victor Babeș ( Site 2701) — Bucharest, Bucharest, Romania
  • Spitalul Clinic De Urgenta Prof Dr Agrippa Ionescu ( Site 2705) — Baloteşti, Ilfov, Romania
  • Centrul Medical SANA ( Site 2704) — Bucharest, Romania
  • National Institute for Infectious Diseases Prof. Dr. Matei Bals ( Site 2706) — Bucharest, Romania
  • National Institute for Infectious Diseases Prof. Dr. Matei Bals ( Site 2707) — Bucharest, Romania
  • Spitalul Clinic de Boli Infecțioase ( Site 2703) — Cluj-Napoca, Romania
  • Spitalul Clinic de Boli Infecțioase ( Site 2702) — Constanța, Romania
  • Wonju Severance Christian Hospital-Internal Medicine ( Site 3009) — Wŏnju, Kang-won-do, South Korea
  • Chonnam National University Hospital-Infectious Diseases ( Site 3008) — Gwangju, Kwangju-Kwangyokshi, South Korea
  • Korea University Ansan Hospital ( Site 3007) — Ansan-si, Kyonggi-do, South Korea
  • Gyeongsang National University Hospital ( Site 3005) — Jinju, Kyongsangnam-do, South Korea
  • Pusan National University Hospital-Internal Medicine ( Site 3010) — Pusan, Pusan-Kwangyokshi, South Korea
  • Kyungpook National University Chilgok Hospital-Division of Infectious Diseases ( Site 3002) — Deagu, Taegu-Kwangyokshi, South Korea
  • Korea University Anam Hospital ( Site 3001) — Seoul, South Korea
  • Hallym University Kangnam Sacred Heart Hospital-Internal Medicine ( Site 3003) — Seoul, South Korea
  • Korea University Guro Hospital ( Site 3006) — Seoul, South Korea
  • Hospital General Universitario de Elche-Infectius Disease ( Site 3105) — Elche, Alicante, Spain
  • Hospital Germans Trias i Pujol ( Site 3101) — Badalona, Barcelona, Spain
  • EAP Osona Sud - Alt Congost S.L.P ( Site 3107) — Centelles, Barcelona, Spain
  • Hospital Universitari Vall d'Hebron ( Site 3102) — Barcelona, Catalonia, Spain
  • Hospital Universitario de A Coruña ( Site 3112) — A Coruña, Galicia, Spain
  • Hospital Santa Lucia-Medicina Infecciosas ( Site 3106) — Cartagena, Murcia, Spain
  • EAP Sardenya ( Site 3109) — Barcelona, Spain
  • Hospital Universitario Infanta Leonor ( Site 3110) — Madrid, Spain
  • HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO ( Site 3100) — Seville, Spain
  • Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 3306) — Kaoshiung, Kaohsiung, Taiwan
  • Taoyuan General Hospital ( Site 3300) — Taoyuan City, Taoyuan, Taiwan
  • Kaohsiung Veterans General Hospital ( Site 3307) — Kaohsiung City, Taiwan
  • Taipei Medical University - Shuang Ho Hospital ( Site 3308) — New Taipei City, Taiwan
  • Taichung Veterans General Hospital ( Site 3305) — Taichung, Taiwan
  • National Taiwan University Hospital ( Site 3301) — Taipei, Taiwan
  • Tri-Service General Hospital ( Site 3304) — Taipei, Taiwan
  • Taipei Municipal Wangfang Hospital ( Site 3309) — Taipei, Taiwan
  • Chang Gung Memorial Hospital - Linkou Branch ( Site 3303) — Taoyuan, Taiwan
  • Faculty of Medicine Siriraj Hospital-Department of Medicine ( Site 3401) — Bangkok, Bangkok, Thailand
  • HIV Netherlands Australia Thailand Research Collaboration ( Site 3402) — Pathumwan, Bangkok, Thailand
  • EUROMEDCLINIC ( Site 3517) — Cherkasy, Cherkasy Oblast, Ukraine
  • MUNICIPAL NON-PROFIT ENTERPRISE CENTRAL CITY CLINICAL HOSPITAL OF CHERNIVTSI CITY COUNCIL ( Site 3513) — Chernivtsi, Chernivetska Oblast, Ukraine
  • Clinical medical and diagnostic center Limited Liability Company "Simedgroup" ( Site 3524) — Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine
  • Regional Phthisiology and Pulmonology Center ( Site 3523) — Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine
  • Private Enterprise Private Manufacturing Company Acinus-Medical and Diagnostic Centre ( Site 3537) — Kropyvnytskyi, Kirovohrad Oblast, Ukraine
  • Limited Liability Company Ukrainian Center of Tomotherapy-Clinical Trials Department ( Site 3512) — Kropyvnytskyi, Kirovohrad Oblast, Ukraine
  • Medical Center "Harmoniya Krasy" ( Site 3545) — Kyiv, Kyivska Oblast, Ukraine
  • Edelweiss Medics ( Site 3503) — Kyiv, Kyivska Oblast, Ukraine
  • Communal Non-Profit Enterprise "Kyiv City Clinical Hospital #1"-Department of Clinical Research ( Site 3514) — Kyiv, Kyivska Oblast, Ukraine
  • Medbud Clinic-Treatment prevention unit ( Site 3506) — Kyiv, Kyivska Oblast, Ukraine
  • Medical Center of Limited ( Site 3546) — Kyiv, Kyivska Oblast, Ukraine
  • Center of Family Medicine Plus ( Site 3502) — Kyiv, Kyivska Oblast, Ukraine
  • Polyclinic of Communal 4th city clinical hospital ( Site 3501) — Lviv, Lviv Oblast, Ukraine
  • Lviv Territorial Medical Union Multidisciplinary Clinical Hospital ( Site 3525) — Lviv, Lviv Oblast, Ukraine
  • University clinic of the National Pirogov Memorial Medical University ( Site 3547) — Vinnytsia, Vinnytsia Oblast, Ukraine
  • Clinic of Scientific and Research Institute of Invalid Rehabilitation of VNMU n.a. M.I.Pyrohov ( Site 3528) — Vinnytsia, Vinnytsia Oblast, Ukraine
  • Municipal Enterprise "Volyn Regional Clinical Hospital" of Volyn Regional Council ( Site 3530) — Lutsk, Volyn Oblast, Ukraine
  • Uzhhorod Municipal Multidisciplinary Clinical Hospital of Uzhhorod City Council ( Site 3538) — Uzhhorod, Zakarpattia Oblast, Ukraine
  • Medlight Clinic ( Site 3548) — Kyiv, Ukraine
  • Kyiv Railway Clinical Hospital No.2 of Branch Health Center -Center of Clinical Trials ( Site 3549) — Kyiv, Ukraine
  • Whiteladies Medical Group ( Site 3611) — Bristol, Bristol, City of, United Kingdom
  • Royal Devon & Exeter Hospital ( Site 3604) — Exeter, England, United Kingdom
  • Royal Victoria Infirmary ( Site 3608) — Newcastle, Newcastle Upon Tyne, United Kingdom
  • Norwich Practices Health Centre ( Site 3605) — Norwich, Norfolk, United Kingdom
  • Oak Street Medical Practice ( Site 3612) — Norwich, Norfolk, United Kingdom
  • Lakeside Surgery ( Site 3600) — Northamptonshire, Northamptonshire, United Kingdom
  • Bicester Health Centre ( Site 3609) — Bicester, Oxfordshire, United Kingdom
  • Banbury Cross Health Centre ( Site 3610) — Oxford, Oxfordshire, United Kingdom
  • Buttercross Health Centre ( Site 3606) — Somerset, Somerset, United Kingdom
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record